Kenya has recorded a 91% uptake of antiretroviral therapy (ART) among people living with HIV, reflecting strong progress despite a significant decline in international donor funding.
Data from the National Syndemic Diseases Control Council (NSDCC) shows that 39 of the country's 47 counties increased access to life-saving HIV medication over the past year. Although the achievement is a major public health milestone, it remains just below the national target of 95%.
Health officials attribute the gains to reforms aimed at protecting HIV services from funding disruptions. The government has integrated HIV care into general outpatient and chronic disease clinics, reducing reliance on stand-alone treatment centres and improving service continuity.
The progress comes amid an 18.2% reduction in Global Fund support for the 2026–2028 period and the termination of USAID-funded HIV programmes worth Sh108.34 billion.
Under the Kenya AIDS Integration Strategic Framework (KAISF) 2026–2030, all 47 counties have developed operational plans tailored to local HIV prevention and treatment needs. Meanwhile, the Ministry of Medical Services is promoting sustainable financing through the Social Health Insurance Fund (SHIF), health bonds and local pharmaceutical manufacturing to reduce dependence on foreign donors by 2030.
Source Attributed: Nation Newspaper